0001209191-23-037405.txt : 20230615
0001209191-23-037405.hdr.sgml : 20230615
20230615170010
ACCESSION NUMBER: 0001209191-23-037405
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230615
FILED AS OF DATE: 20230615
DATE AS OF CHANGE: 20230615
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chin Mark
CENTRAL INDEX KEY: 0001734389
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38503
FILM NUMBER: 231018218
MAIL ADDRESS:
STREET 1: 20 BERKELEY SQUARE, MAYFAIR
CITY: LONDON
STATE: X0
ZIP: W1J 6EQ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Iterum Therapeutics plc
CENTRAL INDEX KEY: 0001659323
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L2
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FITZWILLIAM COURT, 1ST FLOOR
STREET 2: LEESON CLOSE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 YW24
BUSINESS PHONE: (872) 225-6077
MAIL ADDRESS:
STREET 1: FITZWILLIAM COURT, 1ST FLOOR
STREET 2: LEESON CLOSE
CITY: DUBLIN 2
STATE: L2
ZIP: D02 YW24
FORMER COMPANY:
FORMER CONFORMED NAME: Iterum Therapeutics Ltd
DATE OF NAME CHANGE: 20151124
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-15
0
0001659323
Iterum Therapeutics plc
ITRM
0001734389
Chin Mark
C/O ITERUM THERAPEUTICS PLC
FITZWILLIAM COURT, FL. 1, LEESON CLOSE
DUBLIN 2
L2
IRELAND
1
0
0
0
0
Ordinary Shares
2023-06-15
4
M
0
15853
0.00
A
18306
D
Restricted Share Units
2023-06-15
4
M
0
15853
0.00
D
Ordinary Shares
15853
0
D
Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
On August 17, 2022 the Issuer effected a 1 for 15 reverse share split (the "Reverse Share Split"). The number of ordinary shares reported in this Form 4 have been adjusted to reflect the Reverse Share Split.
On June 15, 2022, the reporting person was granted an award of 15,853 RSUs, which vested in full on June 15, 2023.
/s/ Mark Chin
2023-06-15